Aipore
Aipore is a technology company specializing in the area of nanopore sensor using semiconductor Si microfabrication technology.
Aipore is a business in health based in Tokyo, Japan, founded in 2018.
Profile
"Aipore is a technology company specializing in nanopore sensors using semiconductor Si microfabrication technology. Their core technology involves an AI-powered IoT nanoparticle sensor. A notable achievement includes the development of a research testing kit capable of detecting COVID-19 infection from saliva samples within 5 minutes. By flowing saliva through finely processed semiconductor chips with tiny holes that only allow viruses to pass, the system can differentiate virus types through AI analysis of the resulting changes in electric currents. In trials conducted at Osaka University, the kit demonstrated a 95% positive and 92% negative correlation with PCR test results, successfully identifying four types of coronaviruses, including SARS. Aipore is currently focusing on collaborations with research institutions and is exploring regulatory approval for clinical use."
As a business in health, Aipore is listed here with the public details available about it.
Its base of operations is Tokyo, Japan.
It is recorded at the Series_Unknown stage.
Its team size is recorded as c_00001_00010 employees.
It has disclosed roughly $350M in funding.
| Sector | Health |
|---|---|
| Headquarters | Tokyo, Japan |
| Country | Japan |
| Founded | 2018 |
| Employees | c_00001_00010 |
| Stage | series_unknown |
| Total funding | $350,000,000 |
Website: aipore.com
Browse related
Create a free account